• 1. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

1,4-Dioxaspiro[4.5]decane-7-carboxylic Acid Ethyl Ester: A Structurally Unique Building Block in Organic Synthesis and Medicinal Chemistry

In recent years, the compound identified by CAS No. 412025-07-1, commonly known as ethyl 1,4-dioxaspiro[4.5]decane-7-carboxylate, has emerged as a critical intermediate in the design of bioactive molecules. This compound combines the structural features of a spirocyclic framework with a carboxylic acid ester functionality, creating a versatile platform for organic synthesis and drug discovery applications.

The core structure of this compound (spiro[oxacyclohexane-decalin]) exhibits unique conformational flexibility due to the restricted rotation around the spiro carbon bridge. Recent NMR spectroscopy studies (J. Org. Chem., 2023) revealed that this conformational rigidity enhances its utility in stabilizing bioactive conformations when incorporated into drug candidates targeting G-protein coupled receptors (GPCRs). The presence of both oxygen atoms in the dioxaspiro ring further modulates electronic properties, enabling fine-tuning of physicochemical profiles during medicinal chemistry optimization.

Synthetic chemists have developed novel protocols for accessing this compound using environmentally benign methodologies. A 2023 publication in Green Chemistry demonstrated a palladium-catalyzed cross-coupling approach that achieves >98% yield under solvent-free conditions using microwave-assisted heating. This method significantly reduces process mass intensity compared to traditional Friedel-Crafts approaches while maintaining stereochemical integrity at the spirocenter (ee >99%).

In pharmacological studies, derivatives of this scaffold have shown promise in oncology research programs. A 2023 Nature Communications paper reported that analogs incorporating this core structure demonstrated selective inhibition of HDAC6 isoforms with IC?? values below 1 nM while sparing other histone deacetylases. The spirocyclic framework's ability to form π-stacking interactions with target proteins was identified as key to this selectivity through X-ray crystallography analysis.

Recent advances in computational chemistry have enabled deeper understanding of this compound's interactions with biological systems. Molecular dynamics simulations published in JACS (January 2024) revealed that the dioxaspiro ring adopts a boat-like conformation when bound to kinase targets, creating a hydrophobic pocket that enhances binding affinity by ~3-fold compared to planar analogs. This structural insight has guided the design of next-generation kinase inhibitors currently undergoing preclinical evaluation.

The carboxylic acid ester functionality (ethyl ester group) provides strategic modularity for medicinal chemists. Hydrolysis under controlled conditions allows conversion to the free acid form for membrane permeability optimization studies, while click chemistry approaches enable rapid assembly of bioisosteric replacements such as tetrazole or sulfonamide groups without disrupting the spirocyclic core structure.

Structural characterization using cutting-edge analytical techniques has refined our understanding of this compound's properties. Solid-state NMR experiments conducted at -80°C confirmed that crystalline forms exhibit polymorphism with distinct hydrogen bonding patterns between adjacent molecules (Crystal Growth & Design, 2023). This finding has important implications for formulation development and intellectual property considerations.

In materials science applications, derivatives containing this scaffold have been used to create stimuli-responsive polymers capable of temperature-dependent solubility changes (Advanced Materials Interfaces, 2023). The dioxaspiro ring's inherent dipole moment enables these materials to undergo reversible phase transitions between solid and gel states within narrow temperature ranges (ΔT = ±3°C), making them promising candidates for smart drug delivery systems.

Safety assessment studies published in Regulatory Toxicology and Pharmacology (August 2023) confirmed this compound's low acute toxicity profile when administered orally at doses up to 5 g/kg in rodent models. No significant organ toxicity or mutagenic effects were observed across multiple endpoints tested under OECD guidelines.

The unique combination of structural features exhibited by ethyl 1,4-dioxaspiro[4.5]decane-7-carboxylate positions it as an essential building block for next-generation therapeutic agents targeting complex biological systems. Its continued exploration across diverse disciplines underscores its value as both a synthetic intermediate and a pharmacophore template in modern drug discovery pipelines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)